Taprizosin

CAS No. 210538-44-6

Taprizosin( —— )

Catalog No. M34440 CAS No. 210538-44-6

Taprizosin(UK-338003) is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 567 Get Quote
5MG 851 Get Quote
10MG 1169 Get Quote
25MG 1730 Get Quote
50MG 2374 Get Quote
100MG 3060 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Taprizosin
  • Note
    Research use only, not for human use.
  • Brief Description
    Taprizosin(UK-338003) is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.
  • Description
    Taprizosin(UK-338003) is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    210538-44-6
  • Formula Weight
    506.58
  • Molecular Formula
    C25H26N6O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NC=1C=2C(=C(OC)C(OC)=CC2N=C(N1)N3CC=4C(CC3)=C(NS(C)(=O)=O)C=CC4)C5=CC=CC=N5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Fluparoxan hydrochlo...

    Fluparoxan hydrochloride is a highly selective and potent α2-adrenoceptor antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.

  • Asenapine

    A potent psychopharmacologic agent that shows high affinity for 5-HT, dopamine, histamine and adrenoceptors.

  • BRL 37344 sodium

    BRL 37344 is a potent and selective β3 adrenoceptor agonist with Ki of 287 nM; has weaker binding affinity for β1 and β2 receptors with Ki of 1750 and 1120 nM, respectively.